vs
Side-by-side financial comparison of INTRUSION INC (INTZ) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.5M, roughly 1.5× INTRUSION INC). INTRUSION INC runs the higher net margin — -190.7% vs -365.3%, a 174.6% gap on every dollar of revenue. On growth, INTRUSION INC posted the faster year-over-year revenue change (-11.6% vs -19.2%).
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
INTZ vs TIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $2.2M |
| Net Profit | $-2.8M | $-8.2M |
| Gross Margin | 74.3% | — |
| Operating Margin | -192.4% | -426.3% |
| Net Margin | -190.7% | -365.3% |
| Revenue YoY | -11.6% | -19.2% |
| Net Profit YoY | -44.4% | 31.1% |
| EPS (diluted) | $-0.15 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | $2.2M | ||
| Q3 25 | $2.0M | $2.2M | ||
| Q2 25 | $1.9M | $2.2M | ||
| Q1 25 | $1.8M | $2.2M | ||
| Q4 24 | $1.7M | $2.8M | ||
| Q3 24 | $1.5M | $1.5M | ||
| Q2 24 | $1.5M | $0 | ||
| Q1 24 | $1.1M | $0 |
| Q4 25 | $-2.8M | $-8.2M | ||
| Q3 25 | $-2.1M | $-13.6M | ||
| Q2 25 | $-2.0M | $-21.4M | ||
| Q1 25 | $-2.1M | $-28.2M | ||
| Q4 24 | $-2.0M | $-11.9M | ||
| Q3 24 | $-2.0M | $-23.0M | ||
| Q2 24 | $-2.1M | $-14.9M | ||
| Q1 24 | $-1.7M | $-24.3M |
| Q4 25 | 74.3% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 75.7% | — | ||
| Q4 24 | 74.9% | — | ||
| Q3 24 | 77.1% | — | ||
| Q2 24 | 76.0% | — | ||
| Q1 24 | 80.0% | — |
| Q4 25 | -192.4% | -426.3% | ||
| Q3 25 | -108.6% | -670.0% | ||
| Q2 25 | -111.4% | -1045.5% | ||
| Q1 25 | -117.9% | -1363.2% | ||
| Q4 24 | -113.5% | -426.1% | ||
| Q3 24 | -135.5% | -1582.8% | ||
| Q2 24 | -139.2% | — | ||
| Q1 24 | -218.6% | — |
| Q4 25 | -190.7% | -365.3% | ||
| Q3 25 | -106.5% | -606.0% | ||
| Q2 25 | -109.0% | -954.2% | ||
| Q1 25 | -118.2% | -1257.8% | ||
| Q4 24 | -116.8% | -428.8% | ||
| Q3 24 | -136.3% | -1541.9% | ||
| Q2 24 | -141.6% | — | ||
| Q1 24 | -151.7% | — |
| Q4 25 | $-0.15 | $-1.13 | ||
| Q3 25 | $-0.10 | $-2.01 | ||
| Q2 25 | $-0.10 | $-3.24 | ||
| Q1 25 | $-0.11 | $-4.32 | ||
| Q4 24 | $0.19 | $-1.82 | ||
| Q3 24 | $-0.35 | $-3.54 | ||
| Q2 24 | $-0.53 | $-2.29 | ||
| Q1 24 | $-0.94 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $113.9M |
| Total Assets | $10.4M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $6.6M | ||
| Q3 25 | $4.5M | $5.8M | ||
| Q2 25 | $8.4M | $7.7M | ||
| Q1 25 | $10.7M | $15.4M | ||
| Q4 24 | $4.9M | $8.8M | ||
| Q3 24 | $1.1M | $6.7M | ||
| Q2 24 | $1.5M | $6.8M | ||
| Q1 24 | $122.0K | $5.5M |
| Q4 25 | $7.3M | $113.9M | ||
| Q3 25 | $9.8M | $120.4M | ||
| Q2 25 | $11.6M | $131.7M | ||
| Q1 25 | $13.4M | $144.9M | ||
| Q4 24 | $6.3M | $169.4M | ||
| Q3 24 | $2.6M | $176.3M | ||
| Q2 24 | $2.9M | $195.0M | ||
| Q1 24 | $-1.2M | $205.8M |
| Q4 25 | $10.4M | $203.5M | ||
| Q3 25 | $13.7M | $211.8M | ||
| Q2 25 | $16.4M | $231.0M | ||
| Q1 25 | $18.0M | $237.4M | ||
| Q4 24 | $11.5M | $263.6M | ||
| Q3 24 | $7.4M | $272.6M | ||
| Q2 24 | $7.5M | $294.3M | ||
| Q1 24 | $5.7M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-531.0K | $-7.1M |
| Free Cash FlowOCF − Capex | $-549.0K | — |
| FCF MarginFCF / Revenue | -37.1% | — |
| Capex IntensityCapex / Revenue | 1.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-531.0K | $-7.1M | ||
| Q3 25 | $-3.0M | $-10.6M | ||
| Q2 25 | $-1.6M | $-14.8M | ||
| Q1 25 | $-1.7M | $-4.2M | ||
| Q4 24 | $-178.0K | $-10.6M | ||
| Q3 24 | $-2.1M | $-20.1M | ||
| Q2 24 | $-2.9M | $-10.6M | ||
| Q1 24 | $-1.1M | $-14.4M |
| Q4 25 | $-549.0K | — | ||
| Q3 25 | $-3.0M | — | ||
| Q2 25 | $-1.9M | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $-645.0K | — | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $-3.0M | — | ||
| Q1 24 | $-1.2M | — |
| Q4 25 | -37.1% | — | ||
| Q3 25 | -153.2% | — | ||
| Q2 25 | -101.1% | — | ||
| Q1 25 | -117.3% | — | ||
| Q4 24 | -38.5% | — | ||
| Q3 24 | -140.4% | — | ||
| Q2 24 | -202.3% | — | ||
| Q1 24 | -104.2% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.7% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 22.1% | — | ||
| Q4 24 | 27.9% | 0.0% | ||
| Q3 24 | 2.2% | 0.0% | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 5.7% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
